What are the other causes of high gamma‑glutamyl transferase (GGT) cholestasis in neonates?

High GGT Neonatal Cholestasis: Other Causes

High-GGT neonatal cholestasis is primarily caused by biliary obstruction (including biliary atresia), Alagille syndrome, ciliopathies, mitochondrial hepatopathies, PFIC3 (MDR3 deficiency), alpha-1 antitrypsin deficiency, and cystic fibrosis. 1, 2, 3

Genetic and Hereditary Causes

The 2017 Mayo Clinic guideline provides a comprehensive framework for categorizing high-GGT cholestatic disorders 1:

Bile Acid and Phospholipid Transporter Defects

• ABCB4 (MDR3) mutations cause high-GGT PFIC (PFIC3), intrahepatic cholestasis of pregnancy, and gallstone disease 1
• This represents a distinct genetic entity from the more common low-GGT PFIC types (PFIC1 and PFIC2)

Hepatic Development Disorders

Alagille Syndrome is a critical diagnosis to consider:

• Occurs in approximately 1 in 30,000 live births 1
• Caused by mutations in JAG1 (95% of cases) or NOTCH2 (5% of cases) 1
• Characterized by bile duct paucity (ductopenia on liver biopsy) leading to cholestasis
• Associated extrahepatic features include:
  • Cardiac defects (peripheral pulmonary stenosis or tetralogy of Fallot)
  • Distinctive facial features (broad forehead, small pointed chin)
  • Skeletal abnormalities (butterfly vertebrae)
• Only 50% of patients survive into adulthood without liver transplant 1
• Liver transplantation is challenging due to preexisting cardiac defects

Alpha-1 Antitrypsin Deficiency

This is a common metabolic cause of neonatal cholestasis in countries with high prevalence 4:

• Neonates with ZZ phenotype present with severe cholestasis
• May have no biliary excretion on scintigraphy
• Liver biopsy may appear obstructive, mimicking biliary atresia 1
• Critical diagnostic pitfall: Serum α1-antitrypsin concentrations alone are insufficient because α1-antitrypsin is an acute phase reactant and may be falsely elevated during illness 1
• Proper diagnosis requires phenotyping (normal: MM; abnormal: ZZ or SZ; heterozygous: MZ and MS)

Structural and Obstructive Causes

Biliary Atresia

• Most common cause of chronic childhood cholestasis and leading pediatric indication for liver transplantation 5
• Destructive inflammatory process causing fibrosis and obliteration of extrahepatic bile ducts
• Presence of acholic stools makes differentiation from other causes challenging 1
• Time-sensitive diagnosis: Kasai portoenterostomy must be performed within first 2 months of life for optimal outcomes (70% prolonged survival); success rates significantly reduced after 3 months 5

Metabolic and Mitochondrial Causes

Mitochondrial Hepatopathies

Recent evidence demonstrates distinctive biochemical patterns 2:

• Markedly elevated plasma lactate (median 5.8 mmol/L; P<0.001)
• Extremely elevated AFP (median 99,637 ng/mL) compared to biliary obstruction (median 3,662 ng/mL)
• Present with high-GGT cholestasis pattern

Cystic Fibrosis

• Recognized cause of childhood cholestatic disease 5, 3
• Associated with high-GGT pattern

Rare and Emerging Causes

McCune-Albright Syndrome (MAS)

A recently recognized cause of neonatal cholestasis 6:

• Presents with jaundice, pale stools, and neonatal cholestasis soon after birth
• Cholestasis typically self-resolves by 6 months of age
• Biochemical profile shows elevated total bilirubin (median 207 μmol/L), conjugated bilirubin (162 μmol/L), ALT (821 U/L), AST (532 U/L), and GGT (244 U/L)
• Liver histology: canalicular and hepatocellular cholestasis, giant hepatic cell transformation, bile paucity
• GNAS mutations have 83.3-100% positive rate in liver tissue
• May present with extrahepatic features: café-au-lait spots, Cushing's syndrome, hyperthyroidism, renal tubular dysfunction, skeletal abnormalities
• Important caveat: While cholestasis resolves, hepatic lesions persist and have malignant potential

Ciliopathies (IFT122 mutations)

Newly described cause 7:

• Presents with jaundice, distinctive facial features, sagittal craniosynostosis
• Markedly elevated GGT with elevated direct bilirubin, total bile acids, and transaminases
• Liver pathology: giant cell hepatitis with cholestasis and bile duct dysplasia
• Mechanism: impaired ciliogenesis and disrupted ciliary localization of ARL13B and INPP5E

Diagnostic Algorithm Based on GGT Levels

The GGT level serves as a critical initial triage tool 2, 3:

High-GGT Cholestasis Pattern suggests:

1. Biliary obstruction (including biliary atresia)
2. Alagille syndrome
3. Ciliopathies
4. Mitochondrial hepatopathies
5. PFIC3 (MDR3 deficiency)
6. Alpha-1 antitrypsin deficiency
7. Cystic fibrosis
8. McCune-Albright syndrome

Additional Biochemical Red Flags 2:

• Elevated plasma lactate (>5.8 mmol/L): Consider mitochondrial hepatopathies or hemophagocytic lymphohistiocytosis
• Markedly elevated ferritin (>2000 μg/L): Consider HLH or gestational alloimmune liver disease
• Extremely elevated AFP (>20,000 ng/mL): Consider mitochondrial hepatopathies, tyrosinemia, or GALD
• Hypoglycemia with preserved synthetic function: Consider metabolic or endocrine disorders (including PSIS) 8

Common Pitfalls to Avoid

1. Do not rely on serum α1-antitrypsin levels alone for diagnosis—always obtain phenotyping 1
2. Do not delay Kasai procedure beyond 2-3 months in suspected biliary atresia—outcomes deteriorate significantly 5
3. Do not dismiss self-resolving cholestasis (as in MAS) as benign—liver lesions may persist with malignant potential 6
4. Do not overlook endocrine causes when routine treatment fails—consider hypothalamic-pituitary axis abnormalities 8
5. Do not assume venous sampling is more accurate than capillary for bilirubin—this delays treatment without benefit 9

Urgent Referral Criteria

In neonates and infants with conjugated bilirubin >25 μmol/L (>1.0 mg/dL when TSB ≤5 mg/dL), urgent referral to a pediatrician for assessment of possible liver disease is essential 10, 9. Neonatal cholestasis represents a severe medical condition requiring immediate attention to avoid permanent liver and other organ damage 1.